Keywords
Pandemic
COVID-19
Coronavirus
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify the challenges faced by leprosy patients during the COVID-19 pandemic. Methods: The study is an integrative review, for which a survey of articles in the Virtual Health Library (VHL) and PubMed databases was carried out. The descriptors and combinations used were: (LEPRA) AND (COVID-19), (LEPRA) AND (COVD-19) AND (PANDEMIC), (LEPRA) AND (PANDEMIC), (LEPRA) AND (COVID-19), (LEPRA) AND (PANDEMIC), (LEPRA) AND (COVID-19) AND (PANDEMIC). Articles were included that discussed leprosy and the outcome of the disease in the population during the pandemic period, free of charge, in all languages, published since the beginning of the spread of COVID-19, from 2019 to 2022. Results: The health system was reorganized to try to contain the spread of SARS-CoV-2 infection. This fact led to a decrease in the number of professionals available for leprosy sectors in health units, lack of medication, inadequate diagnosis and psychological problems for individuals, with underreporting of cases in several places, such as Brazil. Conclusion: It is suggested professional training in the management of patients with leprosy and the use of this study to outline plans aimed at improving public health programs so that they are not seriously affected by external factors.
References
ABDELMAKSOUD A e GUPTA SK. Management of leprosy patients in the era of COVID-19. Dermatol Therapy. 2020; 33(4): 13631.
ANTUNES DE, et al. Will cases of leprosy reaction increase with COVID-19 infection? PLoS neglected tropical diseases, 2020; 14(7): 0008460.
APONSO S, et al. Multibacillary leprosy unmasked by COVID-19 vaccination. JAAD Case Reports. 2022; 19: 87-89.
ARORA S, et al. Hansen's disease in the era of COVID‐19: An observation on a series of six patients with co‐infection. Dermatologic Therapy, 2021; 34(2): 4827.
BHARDWAJ A, et al. Updates on Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by IADVL SIG Leprosy. Indian Dermatol Online Journal. 2021; 12(1): S24-S30.
BRASIL. Ministério da Saúde. Gabinete do Ministro. Painel Coronavírus. Brasília, 2022.
CÁCERES-DURÁN MÁ. Comportamiento epidemiológico de lá lepra en vários países de América Latina, 2011-2020. Revista Panamericana de Salud Pública. 2022; 46: 14.
CAVALIERO A e QUAO B. GPZL working group assesses challenges and a path forward for leprosy during COVID-19. Leprosy Review, 2020; 91(4): 421-424.
CERQUEIRA SRPS, et al. The influence of leprosy-related clinical and epidemiological variables on the occurrence and severity of COVID-19: a prospective real-world cohort study. PLoS neglected tropical diseases, 2021; 15(7): 0009635.
DA PAZ WS, et al. Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study. Lancet Regional Health-Americas. 2022; 9: 100181.
DA CUNHA VP, et al. Application of the ARIMA Model to Predict Under-Reporting of New Cases of Hansen’s Disease during the COVID-19 Pandemic in a Municipality of the Amazon Region. International Journal of Environmental Research and Public Health, 2021; 19(1): 415.
DE ARAÚJO SANTOS GC, et al. COVID-19 and the incidence of neglected tropical diseases: reflections in times of pandemic. ABCS Health Sciences, 2021; 46: 021102-021102.
DE BARROS B, et al. An assessment of the reported impact of the COVID-19 pandemic on leprosy services using an online survey of practitioners in leprosy referral centres. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2021; 115(12): 1456-1461.
DEPS P, et al. Hansen's disease case detection in Brazil: a backlog of undiagnosed cases due to COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology, 2022; 36(10): 754-755.
DOMINIC S, et al. Impact of Lockdown Restrictions on Treatment of Leprosy: A Retrospective Analysis. Indian Dermatol Online Journal. 2022; 13(3): 370-374.
FAUZIYAH S, et al. How should Indonesia consider its neglected tropical diseases in the COVID-19 era? Hopes and challenges. Biomedical reports. 2021; 14(6): 1-10.
FORMIGOSA e C de AC, et al. Impact of COVID-19 pandemic on notifiable diseases in Northern Brazil. Revista Brasileira em Promoção da Saúde, 2022; 35: 1-11.
GÓMEZ ECHEVARRÍA JR et aç. Lepra, coronavirus, estigmatización. Revista de leprologia Fontilles, 2020; 23 (6): 393-394.
HANAMANTHU V, et al. Comment on "Multibacillary leprosy unmasked by COVID-19 vaccination". JAAD Case Reports. 2022; 26: 1-2.
KURIZKY PS, et al. The challenge of concomitant infections in the coronavirus disease 2019 pandemic era: Severe acute respiratory syndrome coronavirus 2 infection in a patient with chronic Chagas disease and dimorphic leprosy. Revista da Sociedade Brasileira de Medicina Tropical. 2020; 53: 20200504.
LIMA LV, et al. Temporal trend, distribution and spatial autocorrelation of leprosy in Brazil: ecological study, 2011 to 2021. Revista Brasileira de Epidemiologia, 2022; 5(25): 220040.
MAHATO S, et al. Inequities towards leprosy-affected people: A challenge during COVID-19 pandemic. PLoS neglected tropical diseases, 2020; 14(7): 0008537.
MARQUES NP, et al. Impact of the coronavirus disease 2019 on the diagnoses of Hansen's disease in Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 2021; 54: 0251.
MATOS TS, et al. Impact of the COVID-19 pandemic on the diagnosis of new leprosy cases in Northeastern Brazil, 2020. International journal of dermatology, 2021; 60(8): 1003-1006.
MENDONÇA IMS, et al. Impact of the COVID-19 pandemic on care for patients with leprosy: an evaluative study from the perspective of health professionals. Pesquisa, Sociedade e Desenvolvimento, 2022; 11(2): 4111225459-4111225459.
MONDIALE DE LA SANTÉ O, et al. Global leprosy (Hansen disease) update, 2020: impact of COVID-19 on global leprosy control. Relevé épidémiologique hebdomadaire, 2021; 95(36):e417-438.
PINTO F de M, et al. LEPROSY: A LITERATURE REVIEW. 2015.
RATHOD S, et al. Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by SIG Leprosy (IADVL Academy). Indian Dermatol Online Journal. 2020; 11(3): 345-348.
REPSOLD TAR, et al. Hansen’s disease and COVID-19 co-infection in Brazil. International Journal of Dermatology, 2022; 6: 1506-1510.
SANTOS VS, et al. Clinical characteristics and outcomes in patients with COVID-19 and leprosy. Journal of the European Academy of Dermatology and Venereology, 2021; 35(1): 1-2.
TUCKER A, et al. Persons affected by leprosy and the COVID-19 global health crisis: a consultative calls report from GPZL’s emergency response working group 2. Leprosy Review, 2020; 91(4): 425-430.
VAN DOREMALEN, N et al. Aerosol and surface stability of SARS-CoV-2 compared to SARS-CoV-19. New England Journal off medicine, 2020; 382(16): 1564-1567.
XAVIER AR, et al. COVID-19: clinical and laboratory manifestations in the infection by the new coronavirus. Jornal Brasileiro de Patologia e Medicina Laboratorial, 2020; 56.
ZIEMBOWICZ H, et al. The consequences Sars-CoV-2 pandemic on medical education in the combat leprosy. Revista de Epidemiologia e Controle de Infecção, 2022; 12(1): 7-12.